Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Sny crawled time : 12:00 save search
Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
RLYB | News | $1.59 -8.62% -9.43% 280K
|
|
| O: -5.26%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: -4.49%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
GOOGL | News S | $159.18 0.58% 0.58% 22M
|
Technology Services
|
| O: 0.27%
H: 0.0%
C: 0.0%
GOOG | News 4 | $161.05 0.71% 0.7% 19M
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
biopharma
Sanofi Cuts Jobs in U.S. Vaccines Division as Part of Restructuring
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
sanofi
Quebec's INESSS recommends BEYFORTUS for the prevention of RSV for all infants 8 months of age and younger(1)
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.81%
H: 0.0%
C: 0.0%
beyfortus for rsv
AstraZeneca Expands Fasenra’s Label to Children Aged 6 to 11 with Severe Asthma
Published: 2024-04-12 (Crawled : 12:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
label children astrazeneca
MPM BioImpact Appoints Frank Neumann, M.D., Ph.D., Distinguished Expert in Clinical Development, as Entrepreneur Partner
Published: 2024-04-11 (Crawled : 12:00) - mpmcapital.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
VSTM | $9.29 -3.33% -3.44% 79K
|
Health Technology
|
| O: -0.4%
H: 4.84%
C: 4.79%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE
Published: 2024-04-03 (Crawled : 12:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
patent dpx international
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Published: 2024-03-28 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
DRIO | $1.51 4.14% 3.97% 40K
|
Health Technology
|
| O: -4.61%
H: 14.48%
C: 5.52%
financial results
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
vaccine trials
Dyne Therapeutics Announces CEO Transition
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
DYN | $24.98 -1.81% -1.84% 680K
|
Health Technology
|
| O: -13.24%
H: 11.02%
C: 6.37%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: -0.15%
H: 0.23%
C: -0.5%
ceo therapeutics
CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
CTMX | $1.635 -2.68% -2.75% 280K
|
Health Technology
|
| O: -1.76%
H: 3.59%
C: 0.45%
therapeutics
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
MORF | $27.73 -3.55% -3.68% 330K
|
Health Technology
|
| O: -1.58%
H: 5.18%
C: 2.95%
cooper medical simon
GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer
Published: 2024-03-18 (Crawled : 12:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
biopharma
EYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) Published in The Lancet
Published: 2024-03-08 (Crawled : 12:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.0%
H: 0.27%
C: -0.46%
eylea lancet macular injection diabetic
Clinical trials market size in US to grow by USD 5.9 billion from 2022 to 2027, The rise in the number of clinical trials of drugs is the key factor driving market growth, Technavio
Published: 2024-03-06 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.64%
H: 1.7%
C: 0.54%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.2%
H: 0.71%
C: 0.33%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
ICLR | News | $308.79 0.76% 0.76% 960K
|
Health Technology
|
| O: 2.54%
H: 0.22%
C: -2.44%
trials key market
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
IPHA | $2.47 4.22% 4.05% 690
|
Health Technology
|
| O: 0.78%
H: 1.93%
C: 0.97%
iph6501 first study
Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
Published: 2024-02-22 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.26%
H: 1.36%
C: 1.36%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: 0.0%
KYMR | $35.18 -1.48% -1.51% 380K
|
Health Technology
|
| O: 2.92%
H: 7.24%
C: 1.73%
business year update therapeutics financial results
Linvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review
Published: 2024-02-21 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.54%
H: 0.63%
C: 0.09%
fda review treatment
ECO Animal Health Appoints Dr. Joachim Hasenmaier as Non-Executive Director
Published: 2024-02-12 (Crawled : 12:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
health animal
Tent México, A Coalition of 46 Companies, Launches With Shared Commitment to Connect Refugees and Migrants to Jobs in Mexico
Published: 2024-02-07 (Crawled : 12:00) - prnewswire.com
MAN | $77.1 0.86% 0.0% 390K
|
Commercial Services
|
| O: 0.08%
H: 0.26%
C: -1.9%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
MAR | News | $244.04 1.82% 1.78% 2.3M
|
Consumer Services
|
| O: 0.55%
H: 1.58%
C: 0.75%
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Published: 2024-02-02 (Crawled : 12:00) - globenewswire.com
TSVT | $4.28 -7.56% -8.18% 470K
|
|
| O: -1.16%
H: 9.94%
C: 2.34%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 1.4%
H: 0.28%
C: -2.68%
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
|
| O: -1.23%
H: 1.0%
C: 0.17%
year financial results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.